Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 57Recruiting 8Unknown 7Active not recruiting 4Withdrawn 3Terminated 3Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1107INDUSTRY 584NIH 84NETWORK 35OTHER_GOV 15INDIV 5UNKNOWN 4FED 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 3Gastrointestinal 3Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Genitourinary 1Breast 1

Conditions

Colorectal Neoplasms 2Rectal Neoplasms 1Liver Neoplasms 1Colonic Polyps 1Colonic Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × FED × Gastrointestinal × Clear all
NCT01815463 2016-09-27

NIPCON

Corporal Michael J. Crescenz VA Medical Center

Terminated
2,282 enrolled
Gastrointestinal

Colonic Polyps, Adenomatous Polyposis Coli, Colorectal Neoplasms

NCT00216424 2007-11-12

Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid Carcinoma

James A. Haley Veterans Administration Hospital

Phase 4 Terminated
40 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00216437 2007-11-12

Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma

James A. Haley Veterans Administration Hospital

Phase 1 Terminated
30 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡